Other names: Pentadecapeptide, PL14736, PL-10, Bepecin
World Anti-Doping Code Prohibited List 2024: S0- Non-approved Substances (prohibited at all times).
Poison Standard Australia: Listed under Schedule 4 (Prescription only medicines and prescription animal remedies), Appendix D (Additional controls on possession or supply of poisons included in Schedule 4 or 8) and Clause 5 (Poisons for which possession without authority is illegal).
Therapeutic Goods Administration (TGA) Approval: Not approved by the TGA.
What is it? BPC-157 is a synthetically produced peptide. It is an experimental drug which is not approved by TGA or any global regulatory authority for human use. Its use may lead to serious negative health effects.
Uses: BPC-157 is not approved for therapeutic use. It is an experimental compound that has been initially investigated for inflammatory bowel disease and soft tissue, but its benefits have not been substantiated.
Side effects and risks: The toxicity profile of BPC-157 including the short-term and long-term safety of its intake is unknown. Its use may lead to serious health effects.